A clinically relevant gene signature in triple negative and basal-like breast cancer.
Standard
A clinically relevant gene signature in triple negative and basal-like breast cancer. / Rody, Achim; Karn, Thomas; Liedtke, Cornelia; Pusztai, Lajos; Ruckhaeberle, Eugen; Hanker, Lars; Gaetje, Regine; Solbach, Christine; Ahr, Andre; Metzler, Dirk; Schmidt, Marcus; Müller, Volkmar; Holtrich, Uwe; Kaufmann, Manfred.
in: BREAST CANCER RES, Jahrgang 13, Nr. 5, 5, 2011, S. 97.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A clinically relevant gene signature in triple negative and basal-like breast cancer.
AU - Rody, Achim
AU - Karn, Thomas
AU - Liedtke, Cornelia
AU - Pusztai, Lajos
AU - Ruckhaeberle, Eugen
AU - Hanker, Lars
AU - Gaetje, Regine
AU - Solbach, Christine
AU - Ahr, Andre
AU - Metzler, Dirk
AU - Schmidt, Marcus
AU - Müller, Volkmar
AU - Holtrich, Uwe
AU - Kaufmann, Manfred
PY - 2011
Y1 - 2011
N2 - Current prognostic gene expression profiles for breast cancer mainly reflect proliferation status and are most useful in ER-positive cancers. Triple negative breast cancers (TNBC) are clinically heterogeneous and prognostic markers and biology-based therapies are needed to better treat this disease.
AB - Current prognostic gene expression profiles for breast cancer mainly reflect proliferation status and are most useful in ER-positive cancers. Triple negative breast cancers (TNBC) are clinically heterogeneous and prognostic markers and biology-based therapies are needed to better treat this disease.
U2 - 10.1186/bcr3035
DO - 10.1186/bcr3035
M3 - SCORING: Journal article
VL - 13
SP - 97
JO - BREAST CANCER RES
JF - BREAST CANCER RES
SN - 1465-5411
IS - 5
M1 - 5
ER -